Advertisement

Advertisement

BEAT Stock Latest News

HeartBeam Earnings Call: Fast Trials, Slow Revenue Build

Company AnnouncementsHeartBeam Earnings Call: Fast Trials, Slow Revenue Build

HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained

PremiumRatings

HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained

7d ago

HeartBeam reports Q2 EPS (10c) vs (15c) last year

PremiumThe Fly

HeartBeam reports Q2 EPS (10c) vs (15c) last year

9d ago

HeartBeam sees Q3 cash flow in line with Q2

PremiumThe Fly

HeartBeam sees Q3 cash flow in line with Q2

9d ago

HeartBeam Launches New At-The-Market Equity Offering

PremiumCompany Announcements

HeartBeam Launches New At-The-Market Equity Offering

11d ago

Heartbeam, Inc. (BEAT) Q2 Earnings Cheat Sheet

PremiumPre-EarningsHeartbeam, Inc. (BEAT) Q2 Earnings Cheat Sheet

14d ago

HeartBeam Shareholders Shape Governance, Reject Equity Plan Expansion

Company Announcements

HeartBeam Shareholders Shape Governance, Reject Equity Plan Expansion

22d ago

HeartBeam initiated with a Buy at Maxim

The Fly

HeartBeam initiated with a Buy at Maxim

1M ago

HeartBeam awarded U.S. patent for ECG device capabilities

PremiumThe Fly

HeartBeam awarded U.S. patent for ECG device capabilities

1M ago

HeartBeam Receives Nasdaq Notice on Minimum Bid Price

PremiumCompany Announcements

HeartBeam Receives Nasdaq Notice on Minimum Bid Price

2M ago

HeartBeam (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

PremiumTipRanks Newswire

HeartBeam (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

2M ago

HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

PremiumTipRanks Newswire

HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

2M ago

HeartBeam completes patient enrollment in ALIGN-ACS pilot study

PremiumThe FlyHeartBeam completes patient enrollment in ALIGN-ACS pilot study

2M ago

HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy

TipRanks Newswire

HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy

2M ago

HeartBeam restructures to license 3D ECG technology

Company Announcements

HeartBeam restructures to license 3D ECG technology

2M ago

HeartBeam announces strategic shift to ambulatory ECG signal platform

PremiumThe Fly

HeartBeam announces strategic shift to ambulatory ECG signal platform

2M ago

HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

PremiumTipRanks Newswire

HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

2M ago

HeartBeam Grants Founder Performance-Based Equity and Bonus Incentives

PremiumCompany Announcements

HeartBeam Grants Founder Performance-Based Equity and Bonus Incentives

2M ago

HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk

PremiumTipRanks Newswire

HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk

3M ago

HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG

PremiumThe FlyHeartBeam announces peer-reviewed article in JACC on HeartBeam ECG

3M ago

HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection

TipRanks Newswire

HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection

3M ago

HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

The Fly

HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >